Gene · 9507
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential Anti-Inflammatory and Chondroprotective Effect of Luzula sylvatica. | Int J Mol Sci | 2022 | 36613576 | PubTator, text mining | PubMed |
| Co-Targeting Luminal B Breast Cancer with S-Adenosylmethionine and Immune Checkpoint Inhibitor Reduces Primary Tumor Growth and Progression, and Metastasis to Lungs and Bone. | Cancers (Basel) | 2022 | 36612044 | PubTator, text mining | PubMed |
| The Multiple Roles of Periostin in Non-Neoplastic Disease. | Cells | 2022 | 36611844 | PubTator, text mining | PubMed |
| Isthmin-A Multifaceted Protein Family. | Cells | 2022 | 36611811 | PubTator, text mining | PubMed |
| L-type Voltage-Gated calcium channels partly mediate Mechanotransduction in the intervertebral disc. | JOR Spine | 2022 | 36601377 | PubTator, text mining | PubMed |
| An in-depth analysis of the immunomodulatory mechanisms of intervertebral disc degeneration. | JOR Spine | 2022 | 36601372 | PubTator, text mining | PubMed |
| The mechanism study of Miao medicine Tongfengting decoction in the treatment of gout based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2022 | 36595750 | PubTator, text mining | PubMed |
| Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU). | Front Immunol | 2022 | 36591282 | PubTator, text mining | PubMed |
| Exploring the Potential Mechanism of Artemisinin and Its Derivatives in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking. | Comput Math Methods Med | 2022 | 36590764 | PubTator, text mining | PubMed |
| Shared genetic architecture of hernias: A genome-wide association study with multivariable meta-analysis of multiple hernia phenotypes. | PLoS One | 2022 | 36584111 | PubTator, text mining | PubMed |
| Role of Advanced Glycation End Products in Intervertebral Disc Degeneration: Mechanism and Therapeutic Potential. | Oxid Med Cell Longev | 2022 | 36573114 | PubTator, text mining | PubMed |
| Identifying hub genes, key pathways and key immune-related genes in Peyronie's disease by integrated bioinformatic analysis. | Front Pharmacol | 2022 | 36561343 | PubTator, text mining | PubMed |
| TRH Regulates the Synthesis and Secretion of Prolactin in Rats with Adenohypophysis through the Differential Expression of miR-126a-5p. | Int J Mol Sci | 2022 | 36555554 | PubTator, text mining | PubMed |
| Investigation of MicroRNA Biomarkers in Equine Distal Interphalangeal Joint Osteoarthritis. | Int J Mol Sci | 2022 | 36555166 | PubTator, text mining | PubMed |
| Short-Term Exposure to Ciprofloxacin Reduces Proteoglycan Loss in Tendon Explants. | Genes (Basel) | 2022 | 36553476 | PubTator, text mining | PubMed |
| Inhibition of NADPH Oxidases Prevents the Development of Osteoarthritis. | Antioxidants (Basel) | 2022 | 36552552 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis reveals differential cell subpopulations and distinct phenotype transition in normal and dissected ascending aorta. | Mol Med | 2022 | 36536281 | PubTator, text mining | PubMed |
| Astragaloside IV attenuates IL-1β-induced intervertebral disc degeneration through inhibition of the NF-κB pathway. | J Orthop Surg Res | 2022 | 36527065 | PubTator, text mining | PubMed |
| Association of ADAMTS proteoglycanases downregulation with IVF-ET outcomes in patients with polycystic ovary syndrome: a systematic review and meta-analysis. | Reprod Biol Endocrinol | 2022 | 36510316 | PubTator, text mining | PubMed |
| Gene expression profiling in nucleus pulposus of human ruptured lumbar disc herniation. | Front Pharmacol | 2022 | 36506585 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9507/papers?page=19